Cite
HARVARD Citation
Khadadah, F. et al. (n.d.). P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY.. HemaSphere. pp. 603-604. [Online].